81 related articles for article (PubMed ID: 11729932)
1. Pharmacological and immunochemical evidence of the dopamine D3 receptor in the goat carotid body.
Wang ZY; Herman JK; O'Halloran KD; Keith IM; Bisgard GE
Adv Exp Med Biol; 2001; 499():49-53. PubMed ID: 11729932
[No Abstract] [Full Text] [Related]
2. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
[TBL] [Abstract][Full Text] [Related]
3. [Regulation of liberation and metabolism of dopamine in the dorsal striatum of free-living rats: the role of D2- and D3-dopamine autoreceptors].
Gaĭnetdinov RR; Sotnikova TD; Grekhova TV; Raevskiĭ KS
Dokl Akad Nauk; 1994 Aug; 337(6):821-3. PubMed ID: 7981645
[No Abstract] [Full Text] [Related]
4. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
Caine SB; Geyer MA; Swerdlow NR
Neuropsychopharmacology; 1995 Apr; 12(2):139-45. PubMed ID: 7779242
[TBL] [Abstract][Full Text] [Related]
5. Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D3 receptor antagonist.
Dubuffet T; Newman-Tancredi A; Cussac D; Audinot V; Loutz A; Millan MJ; Lavielle G
Bioorg Med Chem Lett; 1999 Jul; 9(14):2059-64. PubMed ID: 10450981
[TBL] [Abstract][Full Text] [Related]
6. The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study.
Waters N; Lagerkvist S; Löfberg L; Piercey M; Carlsson A
Eur J Pharmacol; 1993 Sep; 242(2):151-63. PubMed ID: 8253112
[TBL] [Abstract][Full Text] [Related]
7. Ejaculation induced by i.c.v. injection of the preferential dopamine D(3) receptor agonist 7-hydroxy-2-(di-N-propylamino)tetralin in anesthetized rats.
Clément P; Bernabé J; Denys P; Alexandre L; Giuliano F
Neuroscience; 2007 Mar; 145(2):605-10. PubMed ID: 17258866
[TBL] [Abstract][Full Text] [Related]
8. Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
Piercey MF; Hyslop DK; Hoffmann WE
Brain Res; 1997 Jul; 762(1-2):19-28. PubMed ID: 9262154
[TBL] [Abstract][Full Text] [Related]
9. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D(3) receptors modulate evoked dopamine release from slices of rat nucleus accumbens via muscarinic receptors, but not from the striatum.
Yamada S; Harano M; Annoh N; Tanaka M
J Pharmacol Exp Ther; 1999 Dec; 291(3):994-8. PubMed ID: 10565816
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
Collo G; Zanetti S; Missale C; Spano P
Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
[TBL] [Abstract][Full Text] [Related]
12. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
13. Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat.
Eltayb A; Lindblom S; Oerther S; Ahlenius S
Acta Physiol Scand; 2001 Jul; 172(3):205-9. PubMed ID: 11472307
[TBL] [Abstract][Full Text] [Related]
14. Lack of discrimination by agonists for D2 and D3 dopamine receptors.
Burris KD; Pacheco MA; Filtz TM; Kung MP; Kung HF; Molinoff PB
Neuropsychopharmacology; 1995 Jul; 12(4):335-45. PubMed ID: 7576010
[TBL] [Abstract][Full Text] [Related]
15. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
Rogóz Z; Skuza G
Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
[TBL] [Abstract][Full Text] [Related]
16. Functional relevance of dopamine receptors.
Seabrook GR; Patel S; Hutson PH; Ragan CI; Bristow LJ
Trends Pharmacol Sci; 1995 Dec; 16(12):406-8. PubMed ID: 8578612
[No Abstract] [Full Text] [Related]
17. Positron emission tomography (PET) study: the effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP, SUN 0588) on the central dopamine D1, D2 and D3 receptors in rhesus monkey.
Tani Y; Ishihara T; Kanai T; Ohno T; Onoe H; Watanabe Y; Andersson J; Lilija A; Westerberg G; Hartvig P
Adv Exp Med Biol; 1993; 338():327-30. PubMed ID: 8304130
[No Abstract] [Full Text] [Related]
18. Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens.
Patel J; Trout SJ; Palij P; Whelpton R; Kruk ZL
Br J Pharmacol; 1995 Jun; 115(3):421-6. PubMed ID: 7582452
[TBL] [Abstract][Full Text] [Related]
19. Will new dopamine receptors offer a key to schizophrenia?
Taubes G
Science; 1994 Aug; 265(5175):1034-5. PubMed ID: 8066441
[No Abstract] [Full Text] [Related]
20. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
Malmberg A; Nordvall G; Johansson AM; Mohell N; Hacksell U
Mol Pharmacol; 1994 Aug; 46(2):299-312. PubMed ID: 8078492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]